A detailed history of Greenleaf Trust transactions in Viatris Inc stock. As of the latest transaction made, Greenleaf Trust holds 31,863 shares of VTRS stock, worth $414,219. This represents 0.0% of its overall portfolio holdings.

Number of Shares
31,863
Previous 30,378 4.89%
Holding current value
$414,219
Previous $322,000 14.6%
% of portfolio
0.0%
Previous 0.0%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 22, 2024

BUY
$10.32 - $12.13 $15,325 - $18,013
1,485 Added 4.89%
31,863 $369,000
Q2 2024

Jul 22, 2024

BUY
$10.05 - $12.02 $4,060 - $4,856
404 Added 1.35%
30,378 $322,000
Q1 2024

Apr 29, 2024

BUY
$11.27 - $13.53 $2,693 - $3,233
239 Added 0.8%
29,974 $357,000
Q4 2023

Jan 31, 2024

SELL
$8.77 - $10.85 $117,991 - $145,975
-13,454 Reduced 31.15%
29,735 $322,000
Q3 2023

Nov 09, 2023

BUY
$9.59 - $11.35 $6,818 - $8,069
711 Added 1.67%
43,189 $425,000
Q2 2023

Aug 09, 2023

SELL
$9.02 - $10.29 $2,092 - $2,387
-232 Reduced 0.54%
42,478 $423,000
Q1 2023

May 11, 2023

BUY
$9.2 - $12.26 $42,862 - $57,119
4,659 Added 12.24%
42,710 $410,000
Q4 2022

Jan 25, 2023

BUY
$8.72 - $11.56 $78,113 - $103,554
8,958 Added 30.79%
38,051 $424,000
Q3 2022

Nov 10, 2022

BUY
$8.48 - $11.13 $2,391 - $3,138
282 Added 0.98%
29,093 $248,000
Q2 2022

Aug 12, 2022

SELL
$9.95 - $12.27 $2,039 - $2,515
-205 Reduced 0.71%
28,811 $302,000
Q1 2022

Apr 27, 2022

BUY
$9.81 - $15.4 $7,386 - $11,596
753 Added 2.66%
29,016 $316,000
Q4 2021

Feb 11, 2022

SELL
$12.09 - $14.68 $18,328 - $22,254
-1,516 Reduced 5.09%
28,263 $382,000
Q3 2021

Nov 12, 2021

SELL
$13.25 - $15.13 $37,206 - $42,485
-2,808 Reduced 8.62%
29,779 $404,000
Q2 2021

Aug 10, 2021

SELL
$12.97 - $16.15 $58,455 - $72,788
-4,507 Reduced 12.15%
32,587 $466,000
Q1 2021

Apr 30, 2021

SELL
$13.59 - $18.54 $134,622 - $183,657
-9,906 Reduced 21.08%
37,094 $518,000
Q4 2020

Feb 08, 2021

BUY
$14.3 - $18.74 $672,100 - $880,779
47,000 New
47,000 $881,000

Others Institutions Holding VTRS

About Viatris Inc


  • Ticker VTRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,212,669,952
  • Market Cap $15.8B
  • Description
  • Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...
More about VTRS
Track This Portfolio

Track Greenleaf Trust Portfolio

Follow Greenleaf Trust and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Greenleaf Trust, based on Form 13F filings with the SEC.

News

Stay updated on Greenleaf Trust with notifications on news.